Monday, July 09, 2018 11:59:58 PM
ISR Before the rhetoric begins about the cause and effect of the late corporate news about the warrants lets not forget that:
The company has entered into definitive agreements with several institutional investors for the purchase in a registered direct offering of 11,000,000 shares of its common stock, at a purchase price of $0.75 per share, for gross proceeds of $8.25 million. Additionally, IsoRay has also agreed to issue to the investors unregistered warrants to purchase up to 5,500,000 shares of common stock. The closing of the offering is expected to take place on or about July 11, 2018, subject to the satisfaction of customary closing conditions.
So in other words there should not be any effect on the daily market share price.
Lets just make some $$
GLTA and GO ISR !!!!
Beside the last two minutes of extended hours trading was sick. Wiped out all the bids in the blink of an eye. Just happened to be at the bottom of the bid when low and behold bling bling ---- filled
The company has entered into definitive agreements with several institutional investors for the purchase in a registered direct offering of 11,000,000 shares of its common stock, at a purchase price of $0.75 per share, for gross proceeds of $8.25 million. Additionally, IsoRay has also agreed to issue to the investors unregistered warrants to purchase up to 5,500,000 shares of common stock. The closing of the offering is expected to take place on or about July 11, 2018, subject to the satisfaction of customary closing conditions.
So in other words there should not be any effect on the daily market share price.
Lets just make some $$
GLTA and GO ISR !!!!
Beside the last two minutes of extended hours trading was sick. Wiped out all the bids in the blink of an eye. Just happened to be at the bottom of the bid when low and behold bling bling ---- filled
Recent CATX News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:23 PM
- Perspective Therapeutics to Provide Several Upcoming Corporate Updates • GlobeNewswire Inc. • 04/24/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 10:05:00 AM
- Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting • GlobeNewswire Inc. • 04/20/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 08:10:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 08:10:05 PM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/02/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:16:31 PM
- Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 03/17/2026 08:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/16/2026 08:12:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:36 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results • GlobeNewswire Inc. • 03/16/2026 08:07:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 12:36:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:35:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:34:56 PM
- New Treatment Modalities Are Reaching Cancers That Resisted Everything Else • PR Newswire (Canada) • 02/17/2026 04:17:00 PM
- New Treatment Modalities Are Reaching Cancers That Resisted Everything Else • PR Newswire (US) • 02/17/2026 04:17:00 PM
- Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2026 03:50:42 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/09/2026 09:40:25 PM
